comprehensive -WSS

comprehensive

author：explore 2025-09-30 04:17:49 Page View：26982

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Why do women spend more than men on medical expenses?
Next article： Anesthesiologist group: stop taking Ozempic before surgery

leisure time

Alkermes shareholders re

MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

How the Dana

ThecorporateofficesofMassachusettsGeneralBrighamhospitalsinAssemblySquareinSomerville.LaneTurner/Glo

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

Medicare drug price negotiation program allowed for now

AfederaljudgemadeakeyrulinginalawsuitchallenginganewdrugpricingprogramAdobeWASHINGTON—Afederalcourtj